These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3701064

  • 1. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC, van der Geer P, Bonavida B.
    J Immunol; 1986 May 15; 136(10):3921-9. PubMed ID: 3701064
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC, Bonavida B.
    J Immunol; 1984 Dec 15; 133(6):3415-23. PubMed ID: 6491292
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC, Bonavida B.
    J Immunol; 1983 Jun 15; 130(6):2965-8. PubMed ID: 6189909
    [Abstract] [Full Text] [Related]

  • 4. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B, Katz J.
    J Immunol; 1985 Sep 15; 135(3):1616-23. PubMed ID: 3874903
    [Abstract] [Full Text] [Related]

  • 5. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC, Bonavida B.
    J Immunol; 1985 Apr 15; 134(4):2209-14. PubMed ID: 3855929
    [Abstract] [Full Text] [Related]

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV, Welsh RM, Haspel MV.
    J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb 15; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 8. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC, Bonavida B.
    J Immunol; 1987 Mar 15; 138(6):1791-8. PubMed ID: 3493288
    [Abstract] [Full Text] [Related]

  • 10. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC, Mevissen M, Urli DC, Bonavida B.
    J Immunol; 1987 Sep 01; 139(5):1739-46. PubMed ID: 3624869
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E, Targan SR.
    J Immunol; 1983 Mar 15; 130(3):1252-6. PubMed ID: 6822733
    [Abstract] [Full Text] [Related]

  • 15. Poly-N-acetyllactosamine structures on murine cell surface T200 glycoprotein participate in natural killer cell binding to YAC-1 targets.
    Gilbert CW, Zaroukian MH, Esselman WJ.
    J Immunol; 1988 Apr 15; 140(8):2821-8. PubMed ID: 2965731
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B.
    J Immunol; 1987 Jul 01; 139(1):55-60. PubMed ID: 3584988
    [Abstract] [Full Text] [Related]

  • 17. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 18. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 15; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 20. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.